Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 2 Hyperthermia 2 Breast Neoplasms 2 Uveal Melanoma 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 26 Etoposide 22 Vincristine 18 Melphalan 14 Filgrastim 14 Topotecan 11 Granulocyte Colony-Stimulating Factor 10 Cyclophosphamide 9 Thiotepa 7 Cryotherapy 6 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Drug Therapy 4 Busulfan 4 Radiotherapy 3 Ifosfamide 3 Doxorubicin 3 Temozolomide 2 Platinum Compounds 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 etoposide phosphate 1 cixutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Retinoblastoma × Hyperthermia, Induced × Clear all

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡